home / stock / scps / scps quote
Last: | $0.1682 |
---|---|
Change Percent: | 26.49% |
Open: | $0.25 |
Close: | $0.1682 |
High: | $0.25 |
Low: | $0.1682 |
Volume: | 3,387,508 |
Last Trade Date Time: | 12/16/2022 03:40:50 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.1682 | $0.25 | $0.1682 | $0.25 | $0.1682 | 3,387,508 | 12-16-2022 |
$0.3401 | $0.4977 | $0.3401 | $0.5794 | $0.3316 | 31,434,910 | 12-15-2022 |
$0.2348 | $0.2377 | $0.2348 | $0.2499 | $0.22 | 130,270 | 12-14-2022 |
$0.2451 | $0.2328 | $0.2451 | $0.273 | $0.22 | 350,674 | 12-13-2022 |
$0.24 | $0.21 | $0.24 | $0.38 | $0.2065 | 1,759,770 | 12-12-2022 |
$0.22 | $0.2013 | $0.22 | $0.224 | $0.1951 | 61,935 | 12-09-2022 |
$0.2137 | $0.2207 | $0.2137 | $0.229899 | $0.2005 | 23,902 | 12-08-2022 |
$0.2131 | $0.22 | $0.2131 | $0.2201 | $0.1902 | 44,695 | 12-07-2022 |
$0.2013 | $0.211101 | $0.2013 | $0.225 | $0.1803 | 59,439 | 12-06-2022 |
$0.211 | $0.2329 | $0.211 | $0.2329 | $0.21 | 22,580 | 12-05-2022 |
$0.2215 | $0.215 | $0.2215 | $0.224899 | $0.208801 | 8,046 | 12-02-2022 |
$0.2311 | $0.24 | $0.2311 | $0.24 | $0.2052 | 23,116 | 12-01-2022 |
$0.2202 | $0.218467 | $0.2202 | $0.24 | $0.2046 | 427,479 | 11-30-2022 |
$0.2046 | $0.215 | $0.2046 | $0.215 | $0.195501 | 16,935 | 11-29-2022 |
$0.205 | $0.2059 | $0.205 | $0.2126 | $0.1942 | 40,318 | 11-28-2022 |
$0.2003 | $0.204 | $0.2003 | $0.206 | $0.2 | 25,192 | 11-25-2022 |
$0.1962 | $0.2 | $0.1962 | $0.2081 | $0.19 | 28,755 | 11-24-2022 |
$0.1962 | $0.2 | $0.1962 | $0.2081 | $0.189996 | 28,755 | 11-23-2022 |
$0.2001 | $0.25 | $0.2001 | $0.25 | $0.1682 | 408,346 | 11-22-2022 |
$0.2446 | $0.24 | $0.2446 | $0.2464 | $0.23 | 39,070 | 11-21-2022 |
News, Short Squeeze, Breakout and More Instantly...
Scopus BioPharma Inc. Company Name:
SCPS Stock Symbol:
NASDAQ Market:
DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma Data Suggests Benefits of Combinations of DUET-102 with Other T-Cell Based Immunotherapies, such as CAR-Ts NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Scopus B...
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (OTCQB: “SCPS ”) , a biotechnology company developing transformational therapeutics for serious diseases with significant unmet medical need, and its subsidiary, Duet BioTherapeutics Inc., which is...
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) , a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, and its pure-play immuno-oncology subsidiary, Duet Bi...